Effects of food intake and 4-week multiple curcumin ingestion on pharmacokinetics (bioavailability) of a curcumin supplement
Not Applicable
- Conditions
- Healthy subjects
- Registration Number
- JPRN-UMIN000021406
- Lead Sponsor
- Kobe University Hospital Center for Clinical Research Health Evaluation Research Office
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 9
Inclusion Criteria
Not provided
Exclusion Criteria
- Severe disease history - Currently under treatment - Food or drug allergy - Regular use of curcumin-containing supplements - Pregnant or planned on becoming pregnant - Other unappropriate conditions judged by PI
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Pharmacokinetics parameters (AUC, Cmax, baseline plasma curcumin concetration)
- Secondary Outcome Measures
Name Time Method MDA, 8-OHdG, metabolome